Generate a tailored SOP for Dr. Mandy Ballinger. Improve your application with a focused, well-structured draft.
Mandy Ballinger is an Associate Professor and Deputy Director at the UNSW Centre for Molecular Oncology. She leads the Genetic Cancer Risk Group at the Garvan Institute of Medical Research and serves as Head of Cohorts for the Australian Genomic Cancer Medicine Centre (Omico). With a background in clinical training that includes a Master's degree in Genetic Counselling, Ballinger's research focuses on defining heritable cancer risks and informing clinical risk management in large patient cohort studies. Her work includes studies such as the International Sarcoma Kindred Study and genetic cancer risk studies in pediatric patients. Ballinger's contributions have significantly impacted clinical practices related to Li Fraumeni syndrome, facilitating early cancer detection through the development of a Medicare item number for whole-body MRI. She has supervised important studies in comprehensive genomic profiling for over 23,000 cancer patients in Australia and has been recognized with the 2023 Liddy Shriver Early Career Research Award for her impactful research.
UNSW Centre for Molecular Oncology • Kensington, Australia
Oversees the operations and direction of the Centre focusing on molecular oncology research.
Garvan Institute of Medical Research • Kensington, Australia
Leads a group focused on genetic cancer risks and their implications for treatment.
Australian Genomic Cancer Medicine Centre (Omico) • Kensington, Australia
Responsible for patient cohorts and the integration of research with clinical practice.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.